Adequacy to immunosuppression management guidelines in kidney transplant recipients with severe COVID-19 pneumonia: a practice survey
IntroductionCoronavirus disease 2019 (COVID-19) poses an important risk of morbidity and of mortality, in patients after solid organ transplantation. Recommendations have been issued by various transplantation societies at the national and European level to manage the immunosuppressive (IS) regimen...
Main Authors: | Amélie Jacq, Christelle Auvray, Mathieu Blot, Belaïd Bouhemad, Alice Casenaz, Baptiste Lamarthée, Mathieu Legendre, Jean-Pierre Quenot, Gilbert Zanetta, Claire Tinel |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-03-01
|
Series: | Frontiers in Transplantation |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/frtra.2024.1305152/full |
Similar Items
-
CMV Infection and Lymphopenia: Warning Markers of Pneumocystis Pneumonia in Kidney Transplant Recipients
by: Isabelle Eberl, et al.
Published: (2024-01-01) -
Humoral and cellular immune response after severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccination in heart transplant recipients: An observational study in France
by: Alice Casenaz, et al.
Published: (2022-10-01) -
A case of varicella zoster infection in kidney transplant recipient using immunosuppressant
by: Abdirahim Ali Nur Adam, et al.
Published: (2023-09-01) -
Invasive bacillary angiomatosis in a kidney transplant recipient: A challenging case on belatacept immunosuppression
by: Rita Eid, et al.
Published: (2023-08-01) -
Delayed exacerbation of COVID-19 pneumonia in vaccinated kidney transplant recipients receiving immunosuppressants: a case series
by: Tae Hyun Ryu, et al.
Published: (2023-03-01)